Skip to main content
IDF logo

SCID.net

This site contains information about Severe Combined Immune Deficiency (SCID) with links to journal articles, latest research developments and patient support.

Hyper IgM Foundation

The Hyper IgM Foundation works to improve the treatment, quality of life and the long term outlook for children and adults living with Hyper IgM Syndrome through research, support, education and advocacy to families and patients.

Hereditary Angioedema Association, Inc. (US HAEA)

Founded and staffed by HAE patients and HAE patient caregivers, the U.S. Hereditary Angioedema Association, Inc. (US HAEA) is a nonprofit patient advocacy organization dedicated to serving persons with angioedema. The Association provides HAE patients and their families with a support network and a wide range of services including physician referrals, and individualized patient support.

Chronic Granulomatous Disease Association of America

The Chronic Granulomatous Disease Association of America (CGDAA) is committed to advocating on behalf of patients, carriers, and families by providing clear, accurate, and independent news and information about CGD and advancing CGD research.

Chronic Granulomatous Disease Association

The Chronic Granulomatous Disease Association (CGDA), founded in 1982, is a nonprofit international support group for persons with chronic granulomatous disease (CGD), their families, and physicians. The organization networks patients with similar CGD-related illnesses or infecting organisms. It provides research grants aimed at finding a cure for CGD.

A-T Children’s Project

The A-T Children’s Project is a nonprofit organization that raises funds to support and coordinate biomedical research projects, scientific conferences, and a clinical center aimed at finding a cure for ataxia-telangiectasia, a lethal genetic disease that attacks children, causing progressive loss of muscle control, cancer, and immune system problems.

United States Immunodeficiency Network (USIDNET)

The United States Immunodeficiency Network (USIDNET), is an NIH-funded research program of the Immune Deficiency Foundation (IDF), established to advance scientific research in primary immune deficiency diseases.

Leadiant Biosciences

Chiesi

Chiesi manufactures Revcovi, the only recombinant adenosine deaminase (ADA) approved to treat ADA-SCID in the U.S.

Subscribe to